ArticleInternational journal of nanomedicine2022

Targeted Delivery of Nanovaccine to Dendritic Cells via DC-Binding Peptides Induces Potent Antiviral Immunity in vivo.

Ying Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.